Bone Marrow CD34 Cells+, 500,000 cells, cryopreserved, isolated from mononuclear cells using positive immunomagnetic selection
Bone Marrow CD34+ Cells, 300,000 cells, cryopreserved, positively selected
Human CD34+ Progenitor Cells from Mobilized Peripheral Blood, Positive Selection, 10 Million
Cryopreserved ampule of Human CD34+ Progenitor Cells from Mobilized Peripheral Blood using positive immunomagnetic selection containing 10 million cells
Cryopreserved ampule of Human CD34+ Progenitor Cells from Mobilized Peripheral Blood using positive immunomagnetic selection containing ≥ 25 million cells
Cryopreserved ampule of Human CD34+ Progenitor Cells from Mobilized Peripheral Blood using positive immunomagnetic selection containing ≥ 1 million cells
Cryopreserved ampule of Human CD34+ Progenitor Cells from Mobilized Peripheral Blood using positive immunomagnetic selection containing ≥ 5 million cells
-
Terms and ConditionsCD34+ cells BOGO
-
Primary Normal Human Cells and MediaIn Vivo Relevance. In Vitro Results. Updated and revised cell content.
-
Hematopoietic and Immune Cell Products - Essential Tools for Hematopoietic ResearchLonza_Brochures_Hematopoietic_and_Immune_Cell_Products_-_Essential_Tools_for_Hematopoietic_Research.pdf
-
Instructions and Technical Sheet- Human CD34+ Cells
-
Human Mesenchymal Stem Cells - ImprovedUpgrade Your Path to Better Results
-
Primary Blood and Immune Cells for ResearchPresentation (PDF) showcasing Lonza's portfolio and capabilities of primary blood and immune cells for research.
-
Mitosis of CD34+ cells with Nanolive's 3D Cell Explorer -
CD34+ Cells for Cell and Gene Therapy Process DevelopmentIn this interview Dr. Manon Destalminil, Bioprocessing Project Leader at CellProthera, discusses the advantages of using research-grade CD34+ cells for cell and gene therapy process development. Please register to read.
-
Primary Cells and Media Reference GuideA comprehensive collection of Lonza primary cell and media products supporting many research areas.
-
Blood and Immune CellsFueling your next discovery with unmatched cell and donor variety